Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|February 10, 2017

The Unmet Needs of Patients with GI Cancer

Advertisement

Episodes in this series

EP. 1 The Unmet Needs of Patients with GI Cancer
Now Playing
EP. 1 The Unmet Needs of Patients with GI Cancer

Advertisement
Pancreatic Cancer
|
Liver Cancer
|
Colorectal Cancer
|
Esophageal Cancer
|
Side Effect Management
|
Financial Issues
|
Pulling Back the Curtain: The Unmet Needs of Patients with GI Cancer
|
Raymond Foundation

Related Content

Advertisement
Image of Higgins

Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer

ByDr. Kristin Higgins
August 27th 2026
Image of FDA

FDA Approves Ziihera Combinations for First-Line Treatment of HER2-Positive Gastroesophageal Cancer

ByQuincy Attobrah
August 25th 2026
nurse

This Oncology Nurse Stayed by Her Patient's Side Until His Very Last Days

ByKay Kroeff Streng
August 23rd 2026
stomach

Blood Test May Identify Who Benefits From Sirexatamab in Colorectal Cancer

ByKaitlyn M. Le
August 12th 2026
Image of Kristie

At ASCO, Liver Cancer Advocate Urges Annual CT Scans to Catch HCC

ByKristie L. Kahl
July 28th 2026
Advertisement
Advertisement

Trending on CURE

1

Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer

2

Dolly Parton, 80, Dies Following a Brief Battle with Cancer

3

FDA Approves Rasonque, First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer

4

Prostate Cancer Patients Got the Same Result in Fewer Visits

5

What 35 Years with Polycythemia Vera Reveal About Diagnosis and Hope

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.